PRASAD SUYASH

CIK 00016791292 companiesSAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001679129

Recent Transactions

50 trades

Sale
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2022-07-06$3.79/sh−8,956→ 530,589 total
Sale
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2022-07-05$3.51/sh−3,905→ 539,545 total
Sale
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2022-07-01$3.53/sh−23,923→ 543,450 total
Sale
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2022-06-30$3.72/sh−13,892→ 567,373 total
Sale
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2022-06-29$3.81/sh−12,324→ 581,265 total
Award
Taysha Gene Therapies, Inc.$TSHA
Employee Stock Option (right to buy)
2022-04-06+40,325→ 40,325 total
Award
Taysha Gene Therapies, Inc.$TSHA
Employee Stock Option (right to buy)
2022-02-23+80,650→ 80,650 total
Sale
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2021-07-01$21.12/sh−19,706→ 593,589 total
Sale
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2021-06-30$22.44/sh−6,202→ 613,795 total
Sale
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2021-06-30$21.42/sh−13,374→ 619,997 total
Sale
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2021-06-30$23.70/sh−500→ 613,295 total
Sale
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2021-06-29$23.74/sh−35,056→ 637,533 total
Sale
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2021-06-29$24.46/sh−3,862→ 633,671 total
Sale
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2021-06-29$25.19/sh−300→ 633,371 total
Award
Taysha Gene Therapies, Inc.$TSHA
Stock Option (Right to Buy)
2021-01-19+80,000→ 80,000 total
Conversion
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2020-09-28+3,844→ 672,589 total
Conversion
Taysha Gene Therapies, Inc.$TSHA
Series B Preferred Stock
2020-09-28−3,529→ 0 total
Award
Taysha Gene Therapies, Inc.$TSHA
Common Stock
2020-09-23+668,745→ 668,745 total
Tax Payment
Audentes Therapeutics, Inc.
Common Stock
2019-06-05$37.31/sh−757→ 17,479 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2019-05-13$37.72/sh−54→ 18,236 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Common Stock
2019-05-13$0.79/sh+10,000→ 28,236 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2019-05-13$36.98/sh−9,946→ 18,290 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Stock Option (right to buy)
2019-05-13−10,000→ 30,870 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2019-02-25$30.06/sh−10,000→ 18,236 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Common Stock
2019-02-25$0.79/sh+10,000→ 28,236 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Stock Option (right to buy)
2019-02-25−10,000→ 40,870 total
Award
Audentes Therapeutics, Inc.
Common Stock
2019-02-06+17,500→ 18,236 total
Award
Audentes Therapeutics, Inc.
Stock Option (right to buy)
2019-02-06+48,750→ 48,750 total
Award
Audentes Therapeutics, Inc.
Common Stock
2018-11-15$19.64/sh+736→ 736 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Stock Option (right to buy)
2018-10-01−10,000→ 50,870 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Common Stock
2018-10-01$0.79/sh+4,699→ 4,699 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2018-10-01$35.60/sh−4,699→ 0 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Common Stock
2018-10-01$0.79/sh+1,101→ 1,101 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Common Stock
2018-10-01$0.79/sh+3,900→ 3,900 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2018-10-01$37.82/sh−3,900→ 0 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2018-10-01$39.52/sh−100→ 0 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2018-10-01$38.85/sh−1,101→ 0 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Common Stock
2018-10-01$0.79/sh+100→ 100 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2018-10-01$36.31/sh−200→ 0 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Common Stock
2018-10-01$0.79/sh+200→ 200 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Common Stock
2018-07-02$0.79/sh+4,989→ 4,989 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Stock Option (right to buy)
2018-07-02−4,989→ 65,881 total
Sale
Audentes Therapeutics, Inc.
Copmmon Stock
2018-07-02$38.79/sh−5,011→ 0 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Common Stock
2018-07-02$0.79/sh+5,011→ 5,011 total
Sale
Audentes Therapeutics, Inc.
Common Stock
2018-07-02$38.02/sh−4,989→ 0 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Stock Option (right to buy)
2018-07-02−5,011→ 60,870 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Common Stock
2018-03-29$0.79/sh+7,800→ 7,800 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Stock Option (right to buy)
2018-03-29−7,800→ 70,870 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Stock Option (right to buy)
2018-03-27−300→ 78,670 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Common Stock
2018-03-27$0.79/sh+300→ 300 total

Companies

Recent Filings

Address

C/O AUDENTES THERAPEUTICS, INC. 600 CALIFORNIA STREET, 17TH FLOOR

SAN FRANCISCO, CA, 94108

View on SEC.gov